Skip to main content
Colorado General AssemblyToggle Main Menu
Agency NameToggle Agency Menu

ED0B0CDD31DD20E68725897900586A3C Hearing Summary




PUBLIC
BILL SUMMARY For SB23-041

HOUSE COMMITTEE ON HEALTH & INSURANCE
Date Mar 21, 2023      
Location HCR 0112



SB23-041 - Postponed Indefinitely


10:05:51 AM  

Representatives Amabile and Soper, co-prime bill sponsors, presented Senate Bill 23-041 concerning the authorization of prescription drugs for off-label use. The bill authorizes prescription drugs approved by the Food and Drug Administration (FDA) for off-label use.

10:10:04 AM  
The committee asked
the co-prime bill sponsors questions on the bill.
10:24:14 AM  
Mrs. Erin Meschke,
representing themself, testified in support of the bill and responded to
questions from the committee.
10:27:12 AM  
Nancy Eason, representing
themself, testified
10:32:25 AM  
Jack Teter, representing
Planned Parenthood of the Rocky Mountains, testified in opposition to the
bill.




Ms. Bethany Pray,
representing the Colorado Center on Law and Policy, testified in opposition
to the bill.




The committee
asked the panel questions.
10:53:04 AM  
The co-prime bill
sponsors gave closing comments on the bill.




Committee members
commented on the bill.


10:57:38 AM
Motion Refer Senate Bill 23-041 to the Committee of the Whole.
Moved Soper
Seconded Weinberg
Brown No
Garcia Excused
Hartsook Yes
Lieder No
McCormick No
Ortiz No
Soper Yes
Titone No
Weinberg Yes
deGruy Kennedy No
Daugherty No
YES: 3   NO: 7   EXC: 1   ABS:  0   FINAL ACTION:  FAIL


10:58:05 AM
Motion Postpone Senate Bill 23-041 indefinitely using a reversal of the previous roll call. There was no objection to the use of the reverse roll call, therefore, the bill was postponed indefinitely.
Moved deGruy Kennedy
Seconded Ortiz
Brown Yes
Garcia Excused
Hartsook No
Lieder Yes
McCormick Yes
Ortiz Yes
Soper No
Titone Yes
Weinberg No
deGruy Kennedy Yes
Daugherty Yes
Final YES: 7   NO: 3   EXC: 1   ABS:  0   FINAL ACTION:  PASS